“…These cells are positive for surface markers CD13, CD29, CD44, CD73, CD90, CD105, CD166, while are negative for other markers, such as CD14, CD31, CD45 (Mazzoni et al, 2020). Cells were expanded in Dulbecco's Modified Eagle Medium F-12 (DMEM/F12; Lonza, Milan, Italy), supplemented with 10% fetal bovine serum (FBS) and 10% antibiotics (Pen/Strep 10.000 U/ml) at a density of 5,000 cells/cm 2 , in a T75 flask (Falcon BD, Franklin Lakes, NJ, United States) at 37 • C with 5% CO 2 in a humidified atmosphere (Manfrini et al, 2013;Mazzoni et al, 2017Mazzoni et al, , 2020. At the second passage, hASCs were randomly assigned to five treatment groups: hASCs grown in monolayer in 24-well tissue culture polystyrene plates (TCP) and hASCs grown on biomaterials, such as (i) S-HA, (ii) S-MgHA, (iii) S-MgSrHA, (iv) S-MgZnHA.…”